FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 33552 - BOARD OF SCIENTIFIC COUNSELORS NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES AND NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION - Agency Authority

GENERAL INFORMATION

Committee Name	BOARD OF SCIENTIFIC COUNSELORS NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES AND NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION	Agency Name	Department of Health and Human Services
Fiscal Year	2011	Committee Number	33552
Original Establishment Date		Committee Status	Terminated
Actual Termination Date	12/30/2010	Committee URL
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	15
Terminated This FY	Yes	Designated Fed Officer Position Title*	DFO
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	11/5/2009	Designated Federal Officer First Name*	Esther
Date Of Renewal Charter		Designated Federal Officer Middle Name
Projected Termination Date		Designated Federal Officer Last Name*	Sumartojo
Exempt From Renewal*	No	Designated Federal Officer Suffix	Ph.D.
Specific Termination Authority		Designated Federal Officer Phone*	(404) 498-3800
Establishment Authority*	Agency Authority	Designated Federal Officer Fax*	(404) 498-3070
Specific Establishment Authority*	42 U.S.C. 217A	Designated Federal Officer Email*	esumartojo@cdc.gov
Effective Date Of Authority*	11/5/2007
Exempt From EO 13875 Discretionary Cmte
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Terminate
Legislation to Terminate Required	No
Legislation Status	Enacted
How does cmte accomplish its purpose?*	The Board of Scientifc Counselors (BSC) advises the Director, CDC, concerning strategies and goals for intramural programs and research within the national Centers and monitors the overall strategic direction, focus, and success of the national Centers by conducting periodic reviews then submitting a written description of the results of the review and its recommendations to the Director, CDC.
How is membership balanced?*	The members represent an array of factors, including but not limited to, sex, race/national origin, subject-matter expertise, and geographic location. Members should be authorities knowledgeable in the fields relevant to the issues addressed by the National Centers (e.g., medical, academic, state health, city health, business, foundation, insurance, infant/toddler, schools, adult, older adult, diaparities, international, chronic disease, birth defects, developmental disabilities, media, and the public.
How frequent & relevant are cmte mtgs?*	The BSC reviews NCCDPHP as an organizational unit for the significance, quality, and relevance of its coordinated activities. The BSC reviews the programs and science of NCBDDD to aid in that Centers strategic planning. These functions are relevant to assuring CDC's mission at the most basic level. The committee did not meet in FY11.
Why advice can't be obtained elsewhere?*	HHS agencies, e.g. NIH and CDC, look to external review to assure the quality and relevance to mission of agency science and programs. The BSC, NCBDDD and NCCDPHP will continue in this essential role.
Why close or partially close meetings?	N/A
Recommendation Remarks	No meetings were held in FY11 therefore there were no costs or reports required.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	No
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	Yes	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	Yes
Outcome Increased Customer Satisfaction	Yes	Action Comment	Approximately 75% of the BSC's recommendations have been fully implemented. Some recommendations are beyond the direct control of the Centers (e.g., Leadership Management budget line). Given the limited availability of funding, programs continue to investigate opportunities for leveraging existing funding and collaborating with other agencies (e.g., HRSA/MCHB) to achieve the goal of integrated chronic disease programs in all states.
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	Yes	Number Of Grants Reviewed	0
Outcome Comment	The review of the BSC responded to the need for NCCDPHP review of the Center as an organizational unit (rather than individual programs) at CDC, and to a need for strategic planning for NCBDDD which would enhance alignment of programs and science with the CDC public health mission.	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	The committee did not meet in FY11.	Grants Review Comment	NA
Number Of Recommendations*	53	Access Contact Designated Fed. Officer*	No
Number Of Recommendations Comment	The BSC approved approximately 53 total Recommendations for the two National Centers that were approved at the September 15, 2009 meeting. Thirty-five were related to the work of NCCDPHP and 18 related to the work of NCBDDD. Some broader Recommendations included more specific elemental Sub-Recommendations. The BSC counted both broad and elemental Recommendations to derive the total 53 Recommendations.	Access Agency Website	Yes
% of Recs Fully Implemented*	75.00%	Access Committee Website	No
% of Recs Fully Implemented Comment	In response to the BSC's recommendations, the following steps were taken:NCBDDD: a) conducted a detailed program review of all Division's activities related to DVT and identified gaps; b) invited a group of experts to advise on best approaches to conduct surveillance of DVT; c) worked with five thrombosis centers to define data items needed to better identify risk factors for DVT; d) organized a panel of experts to assess the future use of imaging or other digital imaging data in DBDDD surveillance systems; e) developed two biobanks through the NBDPS and SEED; f) DBDDD's completing an update of its strategic plan; g)expanding mission to include morbidity and quality of life outcomes associated with BD and DD; and, h) expanding efforts in ealry detection and intervention, especially in primary care settingsNCCDPHP: The BSC report included recommendations centered on the use of the social-ecological model as a unifying theoretical framework for programs. This model offers a structure for the Center’s ongoing efforts in program integration. The Center directly addressed the remaining recommendations. These include improving collaborations, evaluating programs within the Center, and supporting capacity development. In the area of collaboration, there are multiple opportunities to work with partners at all levels of HHS. Many NCCDPHP research and program activities reflect deep and broad collaborations with other HHS Agencies including NIH. NCCDPHP currently has a number of projects that are co-funded/collaborative with NIH, HRSA, and OPA to leverage funding for increased impact. In addition, all CDC research funding announcements are listed in the NIH Guide to Grants and Contracts to facilitate collaboration internally and externally.The recommendations covered a broad range of topic areas and were at the level of the Center as an operational unit rather than at the program-specific level. The actions that will emerge from these recommendations are increased collaboration and support for ongoing evaluation of existing programs and increased effectiveness and impact of Center programs. NCCDPHP appreciates the BSC’s careful and thorough review and will continue to work to ensure implementation of its recommendations	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	25.00%	Access Publications	No
% of Recs Partially Implemented Comment	NCBDDD agrees that incorporation of imaging studies into birth defects surveillance is an important research tool for future use; however, prior to convening a panel of experts, believes it would be beneficial to have a better understanding of how brain imaging has been used by other developmental disability surveillance and research entities to inform their work.NCCDPHP concurred with the BSC's recommendations, but noted that a small number of recommendations were beyond their direct control (e.g., increasing the Leadership and Management budget line). The BSC emphasized the need for programs in all major chronic disease areas in all states, as well as further integration of these programs. Center and Division leadership are strongly committed to expansion and integration of programs. Given the limited availability of funding, programs continue to investigate opportunities for leveraging existing funding and collaborating with other agencies (e.g., HRSA/MCHB) to achieve the goal of integrated chronic disease programs in all states.	Access Other	No
Agency Feedback*	Yes	Access Comment	N/A
Agency Feedback Comment*	Agency feedback is provided via email to BSC members. Teleconferences will be scheduled as needed to further discuss BSC recommendations.	Narrative Description*	The mission includes the identification of preventable health problems and maintenance of active surveillance of disease through epidemiologic and laboratory investigations and data collection, analysis, and distribution. For example, with regard to surveillance, the BSC recommended development of clear case definitions for disabilities to be implemented across surveillance systems and that multiple data systems should be used to their maximum efficiency to provide comprehensive surveillance for specific diseases using diabetes surveillance as a model.

COSTS

1. Payments to Non-Federal Members*	$0.00	1. Est Paymnts to Non-Fed Membrs Nxt FY*	$0.00
2. Payments to Federal Members*	$0.00	2. Est. Payments to Fed Members Next FY*	$0.00
3. Payments to Federal Staff*	$0.00	3. Estimated Payments to Federal Staff*	$0.00
4. Payments to Consultants*	$0.00	4. Est. Payments to Consultants Next FY*	$0.00
5. Travel Reimb. For Non-Federal Membrs*	$0.00	5. Est Travel Reimb Non-Fed Membr nxtFY*	$0.00
6. Travel Reimb. For Federal Members*	$0.00	6. Est Travel Reimb For Fed Members*	$0.00
7. Travel Reimb. For Federal Staff*	$0.00	7. Est. Travel Reimb to Fed Staf Nxt FY*	$0.00
8. Travel Reimb. For Consultants*	$0.00	8. Est Travel Reimb to Consltnts Nxt FY*	$0.00
10. Other Costs	$0.00	10. Est. Other Costs Next FY*	$0.00
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified		Est. Fed Staff Support Next FY*	0.00
Federal Staff Support (FTE)*	0.00	Est Cost Remarks
Cost Remarks

Interest Areas

No interest areas selected for this committee.

Custom Links

Committee Level Reports